OVERVIEW

We are pleased to announce the 17th Biennial Meeting of the Diabetes in Pregnancy Study Group of North America will take place at Inova Fairfax Hospital, Physicians Conference Center on Thursday-Saturday, October 26-28, 2023. The theme of the meeting is “Defining Research and Care in Diabetes in Pregnancy,” and will feature internationally and nationally recognized experts who play an active role in a patient’s care from before conception, through the stages of pregnancy and delivery, to her long-term wellbeing.

The DPSG-NA was founded in 1997 out of the recognition that the field of maternal-fetal medicine should support and conduct research to address the specialized needs of pregnant women with type 1, type 2, or gestational diabetes mellitus.  Collaboration among basic, translational, and clinical researchers and care centers, both in the United States and abroad, has occurred through annual and biennial meetings. Only through a collaborative, multi-faceted approach can we ever hope to overcome the health burden and devastation that pregnancies complicated by diabetes can bring to a family.

TARGET AUDIENCE

This event is intended for all healthcare professionals and biomedical researchers with a special interest in the treatment of pregnant women with diabetes, including:

• Basic, Translational and Clinical Research Scientists
• Diabetes Educators 
• Endocrinologists
• Family Practitioners
• Fellows
• Gynecologists
• Internists
• Maternal-Fetal Medicine Subspecialists
• Midwives
• Neonatologists
• Nurses and Nurse Practitioners
• Obstetricians
• Physicians’ Assistants
• Nutritionists
• Residents
• Students

LEARNING OBJECTIVES

• Identify innovative strategies to improve care to pregnant individuals with diabetes and their fetuses.
• Recognize the social determinants of health in caring for patients at high risk for pregnancy complications due to comorbidities or health disparities.
• Identify tools to improve evidence-based care of individuals with diabetes in pregnancy. 
• Explain placental adaptations and their effects prevention, outcome, and long-term health
• Identify glycemic targets with a personalized medicine focus to improve outcomes for mothers and their offspring.
• Determine the risks of hypoglycemia associated with intensive insulin therapy of type I diabetes during pregnancy.

ACCREDIATION

Inova CME Accreditation
The Inova Office of Continuing Medical Education is accredited by the Medical Society of Virginia to provide continuing medical education for physicians.

Credit Designation
The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 16.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 16.75 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.

For more information please visit the official event page.